Blog
AstraZeneca and Oxford University gain approval on new COVID-19 vaccine
The UK has now approved its second vaccine for COVID-19. Last week, AstraZeneca (Pharmaceutical company) and Oxford University’s vaccine was approved for use and has since been administered to the public. From this week there will be half a million doses available for...
Is the pharma industry ready to listen directly to patients?
COO Elizabeth Fairley was recently interviewed by publisher Drug Discovery World on whether the pharmaceutical industry is ready to listen directly to patients? Elizabeth commented that "There has been a growing realisation that pharmaceutical companies must change if...
Pfizer and BioNTech gain approval on new COVID-19 vaccine
This long-awaited moment has finally arrived! This morning, Pfizer and BioNTech’s vaccine has been approved for use in the UK as early as next week. It is the fastest vaccine ever to be developed, taking only 10 months to convert the concept into reality, a process...
Protecting Your Medical Data with Elizabeth Fairley and Ellie Halliday
DIGIT spoke with Elizabeth Fairley and Ellie Halliday of Talking Medicines about keeping your medical data safe in a Covid world. Medical data is among the most sensitive information a company can gather, store or track, and the coronavirus pandemic has heightened...
COVID-19 Vaccine: A fresh start
There is no doubt that 2020 has been a long, hard year. With the endless threat of new measures and long lockdowns, it is safe to say we could do with some good news. Finally, we have a glimmer of hope. First, Pfizer (Pharmaceutical company) announced the interim...
Talking Medicines identified as top AI Company
Data tech innovator Talking Medicines, which uses advanced AI to provide pharmaceutical companies with real-time data intelligence, has been chosen to join Tech Nation’s Applied AI 2.0 Growth Programme. Tech Nation’s growth programmes are designed to champion and...
Talking Medicines builds a world class team
Hot off of the press on raising £1.1M Talking Medicines are building out a world class product and tech team to realise its mission of creating the world’s first social intelligence company for the pharmaceutical industry. In line with plans to scale up its AI-based...
Talking Medicines secures new funds from Tern PLC
Talking Medicines, the world’s first social intelligence company for the pharmaceutical industry, has received a significant boost with a £1.1 million funding deal to scale up its AI-based data technology platform for measuring patient sentiment. Tern Plc, the...
MedTech Integrates – The importance of listening to patient need
A couple of weeks ago our COO, Dr Elizabeth Fairley took part in a panel discussion about the feasibility of MedTech in the developing world and whether it can be a sustainable model.2 We represent a different proposition to the other panellists, their experience is...